AXIOM INVESTORS LLC /DE

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1109147 GREENWICH, CT

Position in SUPN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,393,567

-$4,082,455 QoQ

Shares Held

94,465

-42.4% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#65

of 331 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 77% Shared 0% None 23%

Healthcare · as of Jun 30, 2026

AXIOM INVESTORS LLC /DE holds $33,889,166 across 2 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (13.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	UTHR	UNITED THERAPEUTICS Corp	54,437	$29,495,599
2	SUPN	Supernus Pharmaceuticals, Inc. This page	94,465	$4,393,567

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,393,567	94,465	-42.4%	Shares	Sole	2026-08-12
2026-03-31	$8,476,022	163,978	+54.4%	Shares	Sole	2026-05-14
2025-12-31	$5,277,394	106,185	+1.5%	Shares	Sole	2026-02-11
2025-09-30	$5,000,554	104,636	+86.5%	Shares	Sole	2025-11-14
2025-06-30	$1,768,744	56,115	+3.2%	Shares	Sole	2025-08-07
2025-03-31	$1,780,781	54,375	-22.2%	Shares	Sole	2025-05-14
2024-12-31	$2,527,439	69,896	+38.9%	Shares	Sole	2025-02-12
2024-09-30	$1,569,445	50,335	-8.2%	Shares	Sole	2024-11-12
2024-06-30	$1,467,505	54,860	+1.2%	Shares	Sole	2024-08-13
2024-03-31	$1,849,955	54,235	+11.9%	Shares	Sole	2024-05-13
2023-12-31	$1,402,287	48,455	+255.9%	Shares	Sole	2024-02-12
2023-09-30	$375,365	13,615	-43.0%	Shares	Sole	2023-11-13
2023-06-30	$718,434	23,900	-6.6%	Shares	Sole	2023-08-10
2023-03-31	$927,306	25,595	+26.5%	Shares	Sole	2023-05-12
2022-12-31	$721,960	20,240	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.